Andrea Eigentler
Innsbruck, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer.
Journal: The American journal of pathology
Published: February 18, 2024
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts.
Journal: Oncogene
Published: August 21, 2023
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer.
Journal: Oncogene
Published: November 09, 2020
Antidiabetic drugs influence molecular mechanisms in prostate cancer.
Journal: Cancer biology & therapy
Published: August 02, 2018
Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature.
Journal: International journal of medical sciences
Published: July 24, 2018
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 05, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026